Reports
Reports
Gauge Marketability Across Various Therapeutic Areas
Total Reports: 408
The factors resulting in the development of hypertrophic cardiomyopathy (HCM) therapeutics market include the awareness of the disease and its diagnosis, together with technological improvements in cardiac imaging, facilitating diagnosis of the disease at an early stage and with higher accuracy.
Rep Id : TMRGL7553 | Published | Pharmaceutical | January 2026
Increased use of companion diagnostics and robust development of biomarker testing lead to better patient stratification, which, in turn, implies that a greater number of targeted therapies are utilized.
Rep Id : TMRGL504 | Published | Pharmaceutical | January 2026
Several factors are driving the growth of the opioid-induced constipation treatment market for both - clinical and outpatient settings.
Rep Id : TMRGL6862 | Published | Pharmaceutical | January 2026
Regulatory harmonization and reimbursement-friendly policies drive the market growth, facilitating access by more patients and inclusion of formularies.
Rep Id : TMRGL86927 | Published | Pharmaceutical | January 2026
Improved insurance coverage and increasing healthcare expenditure have expanded access to therapies and propelled affordability, thus driving growth of the asthma and COPD drugs market.
Rep Id : TMRGL86923 | Published | Pharmaceutical | January 2026
India animal healthcare sector has seen robust expansion, driven by a rising awareness of animal health and increasing disposable incomes.
Rep Id : TMRGL23048 | Published | Pharmaceutical | December 2025
Adoption of intraoperative radiation therapy is driven by growing demand for single-session treatments, short hospitalization, and quick recovery, which is in congruence with value-based care models.
Rep Id : TMRGL74059 | Published | Pharmaceutical | December 2025
GLP-1 analogues market is driven by strong clinical evidence demonstrating benefits to the cardiovascular and metabolic systems, growing healthcare spending, and extended reimbursement plans that further enhance patient access.
Rep Id : TMRGL86893 | Published | Pharmaceutical | December 2025
The non-cystic fibrosis bronchiectasis treatment market is witnessing vigorous expansion owing to multiple compelling drivers.
Rep Id : TMRGL86850 | Published | Pharmaceutical | November 2025
The global kidney cancer drugs market is expected to go steady due to the continuous development in targeted therapies and immuno-oncology, increasing aging population, and wider access to diagnostic testing, which make it possible to give the patients earlier and more personalized treatment.
Rep Id : TMRGL537 | Published | Pharmaceutical | November 2025
Increased diagnostic accuracy and wider availability of high-end ocular imaging are significant drivers to the uveal melanoma treatment market.
Rep Id : TMRGL86847 | Published | Pharmaceutical | November 2025
The key factors driving the growth of sarcopenia treatment market are the aging global population, raised awareness of and diagnosis of sarcopenia, the ongoing influx of nutritional supplementation into mainstream, and the emergence of pharmacological therapies such as myostatin inhibitors and SARMs.
Rep Id : TMRGL28547 | Published | Pharmaceutical | November 2025
Multiple key factors drive the expansion of the Barth syndrome therapeutics market.
Rep Id : TMRGL86829 | Published | Pharmaceutical | November 2025
A number of driving forces fuel acromegaly treatment market growth.
Rep Id : TMRGL86824 | Published | Pharmaceutical | November 2025
The global market for controlled drugs steadily expands with the main driver being the escalating cases of chronic pain, neurological disorders, and psychiatric conditions that need medications that are regulated by the authorities.
Rep Id : TMRGL25964 | Published | Pharmaceutical | November 2025
The abortion drugs market grows at the convergence of clinical practice, regulatory diligence, and shifting distribution models.
Rep Id : TMRGL86809 | Published | Pharmaceutical | November 2025
The synthetic cannabinoids market is undergoing acceleration towing to the increased use of cannabinoids-based drugs in various therapies.
Rep Id : TMRGL74674 | Published | Pharmaceutical | October 2025
The monogenetic disease therapy market is witnessing transformative developments due to extensive research being conducted regarding gene-based treatments transitions medicine into a new frontier of therapeutic choices.
Rep Id : TMRGL86769 | Published | Pharmaceutical | October 2025
The anti-infective drug market is witnessing an upward trajectory as scientific technology advancements toward the development of therapeutic agents become more universally accepted.
Rep Id : TMRGL41204 | Published | Pharmaceutical | September 2025
The global erectile dysfunction medicines market is experiencing consistency, buoyed by rising incidences of lifestyle disorders including diabetes, hypertension, obesity, and cardiovascular ailments-prime causes of erectile dysfunction.
Rep Id : TMRGL1550 | Published | Pharmaceutical | August 2025
The ophthalmic drug market is currently witnessing robust growth because of increased prevalence of eye diseases, advancements in pharmaceutical technology, and enhanced global awareness of the importance of eye care. One of the major reasons for this market expansion is rise in the prevalence of eye disorders.
Rep Id : TMRGL1769 | Published | Pharmaceutical | July 2025
The pain management therapeutics market is poised for steady growth, owing to increasing prevalence of chronic pain conditions including arthritis, neuropathic pain, and pain related to cancer – particularly in aging population. North America has the most advanced market due to it being home to established healthcare delivery systems and
Rep Id : TMRGL1059 | Published | Pharmaceutical | July 2025
The market for addiction treatment has expanded significantly over the last two years due to heightened awareness of addiction disorders as well as the wider variety of available treatments. As society's stigma over addiction lessens, more number of patients are seeking the services of the market, which, in turn, is
Rep Id : TMRGL40199 | Published | Pharmaceutical | July 2025
The global psoriasis treatment market is witnessing steadiness, driven primarily by the increase in prevalence of psoriasis, rising awareness and advancements in biologic and targeted therapies. More number of patients are being diagnosed with psoriasis due to the overall increase in healthcare access and improved awareness, which increases the demand
Rep Id : TMRGL17960 | Published | Pharmaceutical | July 2025
The biologics marketplace is growing on an unprecedented note due to visible demand for targeted therapies in conjunction with advancements in biotechnology. Biologics are complex drugs derived from living cells that provide a high level of specificity as well as effectiveness for chronic disease treatment.
Rep Id : TMRGL15509 | Published | Pharmaceutical | July 2025
The active pharmaceutical ingredients (API) market is witnessing a robust growth. This could be attributed to increase in healthcare spending, growing incidences of infectious and chronic diseases, and rising demand for innovative and generic medicines.
Rep Id : TMRGL1690 | Published | Pharmaceutical | May 2025
Development of innovative delivery technologies and advancements in medical expertise are expected to fuel the peptide therapeutics market size. PEGylation is a popular trend in the peptide drug chemical structure, which improves pharmacologic properties by increasing half-life, reducing antigenicity and immunogenicity, and improving solubility.
Rep Id : TMRGL418 | Published | Pharmaceutical | April 2025
The global acute kidney injury treatment market was valued at US$ 3.6 Bn in 2024 and is projected to reach US$ 8.2 Bn by 2035, registering a CAGR of 7.8% from 2025 to 2035. The market is driven by the growing incidence of kidney injuries due to rise in the
Rep Id : TMRGL67523 | Published | Pharmaceutical | April 2025
The market for stroke therapy as growth-promoting, driven by advancements in pharmacologic therapy and a better understanding of stroke pathophysiology. The sector is focusing more on the development of thrombolytic and antiplatelet medications, pivotal in acute stroke treatment for ischemic strokes. Drug delivery systems and formulation science are aiming at
Rep Id : TMRGL73917 | Published | Pharmaceutical | March 2025
Increase in awareness among healthcare professionals and patients regarding rare conditions such as alkaptonuria, ongoing technological advancements in genetic research, rising investments in research and development initiatives, and collaborative regulatory environment are the factors fueling the global alkaptonuria therapeutics market trajectory. Progress in bioanalytical assays and genetic testing has enabled
Rep Id : TMRGL86459 | Published | Pharmaceutical | February 2025
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science - a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
